GENERATION BIO
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies... to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
GENERATION BIO
Industry:
Biotechnology Genetics Health Care
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.generationbio.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
460.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Apton Biosystems
Apton Biosystems develops an optical system designed for sequencing and protein detection.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Strands Hair Care
Strands Hair Care is a provider of personalized hair care products using real biological data.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Foresite Capital
Foresite Capital investment in Series C - Generation Bio
T. Rowe Price
T. Rowe Price investment in Series C - Generation Bio
Deerfield
Deerfield investment in Series C - Generation Bio
Wellington Management
Wellington Management investment in Series C - Generation Bio
Farallon Capital Management
Farallon Capital Management investment in Series C - Generation Bio
Fidelity
Fidelity investment in Series C - Generation Bio
Invus
Invus investment in Series C - Generation Bio
Atlas Venture
Atlas Venture investment in Series C - Generation Bio
Casdin Capital
Casdin Capital investment in Series C - Generation Bio
Casdin Capital
Casdin Capital investment in Series B - Generation Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-10 | Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer |
Official Site Inspections
http://www.generationbio.com Semrush global rank: 2.61 M Semrush visits lastest month: 6.65 K
- Host name: 152.254.209.35.bc.googleusercontent.com
- IP address: 35.209.254.152
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Generation Bio"
Generation Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and …See details»
Generation Bio Co. (GBIO) Company Profile & Facts - Yahoo Finance
See the company profile for Generation Bio Co. (GBIO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Generation Bio Appoints Ron Cooper to Its Board of Directors
Feb 18, 2021 His global commercial experience and current work in rare diseases will be a great addition to our Board and organization as a whole.” ... [email protected]. Media …See details»
Generation Bio Company Profile | Management and Employees …
Generation Bio Profile and History. Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid …See details»
Generation Bio Company Profile 2024: Stock …
Generation Bio General Information Description. Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases.See details»
Generation Bio - LinkedIn
Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral genetic medicine platform ...See details»
Generation Bio - Craft
Oct 22, 2024 Generation Bio is a genetic medicines company creating gene therapy utilizing its non-viral gene therapy platform. It combines three technologies: a cell-targeted lipid …See details»
Our Culture - Generation Bio
Mark was senior vice president of pharmaceutical sciences and rare disease franchise head at bluebird bio Inc. from 2012 until 2016. Previously, he was senior director of research and development and site head in Cambridge, …See details»
Moderna and Generation Bio Announce Strategic Collaboration to …
Mar 23, 2023 For more information, please visit www.generationbio.com. Generation Bio Forward-Looking Statements. Any statements in this press release about future expectations, …See details»
Generation Bio Reports Recent Business Highlights and Third …
For more information, please visit www.generationbio.com. Forward-Looking Statements Any statements in this press release about future expectations, plans and prospects for the …See details»
Generation Bio Announces Strategic Reorganization to Extend …
Nov 29, 2023 Company to invest in highly selective cell-targeted lipid nanoparticle (ctLNP) delivery platform to develop wholly-owned programs for extrahepatic cell typesDevelopment of …See details»
Generation Bio Strengthens Leadership Team with Appointment of …
Apr 9, 2018 Generation Bio was founded and launched by Atlas Venture and is headquartered in Cambridge, Mass. For more information, please visit www.generationbio.com or follow …See details»
Working At Generation Bio: Company Overview and Culture - Zippia
Find out what it's like to work at Generation Bio. See what kind of people work at Generation Bio, career paths working at Generation Bio, company culture, salaries, employee political …See details»
Press Releases - Generation Bio
Apr 2, 2024 ; GenerationBio @generationbio · 18 Oct 2023 1714623628149407952 Today, Generation Bio announced an exciting step forward in our mission to realize the full potential …See details»
Generation Bio Announces Breakthrough in its Non-Viral Genetic …
Oct 18, 2023 For more information, please visit www.generationbio.com. Forward-Looking Statements. Any statements in this press release about future expectations, plans and …See details»
Our Science - Generation Bio
Our mission to offer people everywhere the chance to live unburdened by disease is fueled by our two distinct and complementary platforms. Our highly potent and selective cell-targeted lipid …See details»
Generation Bio Co. (GBIO) - Yahoo Finance Canada
Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle (ctLNP) platform, a modular …See details»
Generation Bio to Present at American Society of Gene & Cell …
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene …See details»
Our Portfolio - Generation Bio
Engineered T cells, specifically CAR-T cells, are a powerful new tool in treating cancer, and recently, autoimmune diseases. However, the current process of delivering cell therapies ex …See details»